Celeris Therapeutics Company
Harnessing deep learning and lab automation to accelerate drug discovery in targeted protein degradation.
Last Funding Type:
Seed
Funding Status:
Seed
Headquarters:
Menlo Park, California, United States
Founded Date:
2021-01-01
Investor Type:
hi@celeristx.com
Last Funding Date:
2022-02-10
Total Funding:
4000000.0
Technology:
['BioTech & HealthTech']
Employee Number:
11-50
Investors Number:
5.0
Industry:
Medical BioTech